To evaluate the feasibility of preoperative chemotherapy, 3 8 conse-
Introduction
In Japan, gastric carcinoma remains the most common cause of death from cancer1). The cumulative five-year survival rates of advanced gastric carcinoma was approximately 46%, even with curative radical operations. Recurrent cases showed mainly peritoneal dissemination, distant lymph node metastasis and hepatic metastasis. To decrease the recurrent rates of curative operations for advanced gastric carcinoma, postoperative adjuvant chemotherapy was introduced2), but no effect from the adjuvant chemotherapy on prognosis was attained3). In the present study, we tried preoperative chemotherapy, especially administering slight toxicity with no negative response. Generally, the purpose of preoperative chemotherapy, so-called neoadjuvant chemotherapy is to undertake down-staging for advanced cancer with metastasis and to proceed to a curative operation4). In this series, we tried to undergo mild chemotherapy by oral administration for a better prognosis for curable surgery cases. Patients and Method
Patients characteristics
We experienced 38 advanced gastric cancer patients resected with preoperative chemo- 
Survival
The survival curves of the gastric cancer patients who underwent preoperative chemotherapy in various stages are shown in Fig. 1 . Five-year survival rates were 78 % in stage II, 46% in stage III and 15% in stage IV. The survival curve of each stage was significantly different by log-rank test. Concerning the prognosis with histopathological effects, the overall five-year survival rate of positive-histopathological-effect cases was 51 %, while the survival rate of negative-histopathological-effect cases (Grade 0) was 14% (P<0.05, log-rank test) as shown in Fig. 2 . In stages II and III, the prognoses for positive histopathological effects were significantly better than those for the negative histopathological effects (P<0.05, log-rank test) as shown in Fig. 3 . On the other hand, the histopathological effects of stage IV cases did not significantly affect the survival of the patients as shown in Fig. 4 . On the prognosis of cases with macroscopic change, the overall five-year survival rate of macroscopic-change-positive cases was 39%, whereas the five year survival rate of macroscopic-change-negative cases was 45% as shown in Fig. 5 . The existence of macroscopic change did not significantly affect the survival of patients.
Discussion
In Japan, the general prognosis for gastric carcinoma has improved over the last decade. 
